OR WAIT null SECS
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
Automation of pharmaceutical packaging saves costs and time, say contract packagers./
CDMOs offer expertise and customization options for sponsors of orphan drugs.
January 18, 2023
Agilent’s $725 million investment is designed to double its capacity to produce APIs.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 15, 2022
In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 02, 2022
Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.
November 01, 2022
The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
October 31, 2022
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
October 21, 2022
Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.